Invention Grant
- Patent Title: Selective degradation of proteins
-
Application No.: US17317798Application Date: 2021-05-11
-
Publication No.: US11306306B1Publication Date: 2022-04-19
- Inventor: Charly Chahwan , Maria Soloveychik
- Applicant: SyntheX, Inc.
- Applicant Address: US CA San Francisco
- Assignee: SyntheX, Inc.
- Current Assignee: SyntheX, Inc.
- Current Assignee Address: US CA San Francisco
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: C12N15/65
- IPC: C12N15/65 ; C12N15/81 ; C12N15/10 ; C12N15/62 ; C12N9/50 ; C12N9/10 ; C07K14/395 ; G01N33/50

Abstract:
The present disclosure provides methods to identify peptides and small molecule moieties that are able to functionally bridge an interaction between a target protein and an E3 ubiquitin ligase to mediate the degradation of the target protein. Some moieties can degrade specific target variants, but not others. The moieties create a neosubstrate for an E3 ligase of interest. The methods described enable generation of compounds able to selectively degrade specific targets within cells with implications for drug development for pathological conditions. The disclosure also describes the generation of modified peptides using post-translational modification enzymes, such as N-methyltransferases, prolyloligopeptidases, lactamases, hydroxylases, and dehydratases, along with methods of using the same.
Information query
IPC分类: